首页> 外文期刊>Nagoya journal of medical science >Primary hepatic carcinosarcoma with multimodal treatment
【24h】

Primary hepatic carcinosarcoma with multimodal treatment

机译:原发性肝癌肉瘤多模式治疗

获取原文
获取外文期刊封面目录资料

摘要

Hepatic carcinosarcoma (HCS) generally presents in advanced stages, demonstrates aggressive behavior, and has a poor prognosis. Other than curative primary resection, no effective treatment options exist. We present a case of resected HCS with four repeat resections for solitary lymph node recurrence followed by chemoradiotherapy with doxorubicin and ifosfamide. A 67-year-old Japanese man was admitted to our hospital for evaluation of an asymptomatic hepatic tumor. The patient underwent right hepatectomy with a presumptive preoperative diagnosis of atypical hepatocellular carcinoma. Based on histopathological and immunohistochemical findings, the tumor was diagnosed as HCS containing osteosarcoma and chondrosarcoma components. After the initial surgery, the patient underwent four additional resections for solitary lymph node HCS recurrence, and then underwent chemoradiotherapy with doxorubicin and ifosfamide for an unresectable lymph node recurrence. Chemotherapy was stopped after two cycles because of severe adverse events, although chemoradiotherapy markedly reduced the size of the lymph node recurrence and provided a progression-free survival of 12 months. Thirty-seven months after the initial surgery, the patient died of cardiac invasion of multiple mediastinal lymph node metastases. The clinical course outlined in this case report suggests that chemoradiotherapy with doxorubicin and ifosfamide for metastatic HCS may prolong survival in patients with unresectable lesions.
机译:肝癌肉瘤(HCS)通常出现在晚期,表现出侵略性行为,并且预后不良。除根治性根治性切除外,没有有效的治疗选择。我们介绍了一个切除的HCS病例,该病例有四个重复切除的孤立性淋巴结复发,然后用阿霉素和异环磷酰胺进行放化疗。一名67岁的日本男子因无症状性肝肿瘤入院接受评估。该患者接受了右肝切除术,并被推定为非典型肝细胞癌的术前诊断。根据组织病理学和免疫组织化学结果,该肿瘤被诊断为含有骨肉瘤和软骨肉瘤成分的HCS。初次手术后,该患者再次进行了四次切除,以实现单发性淋巴结HCS复发,然后接受阿霉素和异环磷酰胺的化学放疗,以治疗无法切除的淋巴结复发。由于严重的不良事件,化疗在两个周期后停止,尽管放化疗显着减少了淋巴结复发的大小,并提供了12个月的无进展生存期。初次手术后37个月,患者死于心脏侵犯多发性纵隔淋巴结转移。本病例报告中概述的临床过程表明,用阿霉素和异环磷酰胺进行的放化疗可治疗转移性HCS,可延长无法切除病灶的患者的生存期。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号